Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?

scientific article (publication date: November 2016)

Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PMED.1002184
P8608Fatcat IDrelease_fpypazb5kzewzpiljvlwgknnsa
P932PMC publication ID5127510
P698PubMed publication ID27898664

P50authorAndrew StewardsonQ42862121
Stephan HarbarthQ63391550
P2093author name stringMarlieke E A de Kraker
P2860cites workMortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in EuropeQ28477449
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort studyQ37205523
Benchmarking the incidence and mortality of severe sepsis in the United StatesQ45240119
Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection.Q50791978
Hospital-acquired infections--appropriate statistical treatment is urgently needed!Q51163990
Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012.Q51241980
The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudmonas aeruginosa on length of hospital stayQ77762612
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectantibiotic resistanceQ380775
multiple drug resistanceQ643839
antimicrobial resistanceQ63391344
P304page(s)e1002184
P577publication date2016-11-01
P1433published inPLOS MEDICINEQ1686921
P1476titleWill 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
P478volume13

Reverse relations

cites work (P2860)
Q64898179A Genomic, Evolutionary, and Mechanistic Study of MCR-5 Action Suggests Functional Unification across the MCR Family of Colistin Resistance.
Q49588634A crucial list of pathogens
Q57288616A microsimulation model projecting the health care costs for resistance to antibacterial drugs in Sweden
Q61815779Adjunct phage treatment enhances the effectiveness of low antibiotic concentration against Staphylococcus aureus biofilms in vitro
Q52657335Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries.
Q92814458Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria
Q89720702Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates
Q91853420Antibiotic resistance, stewardship, and consumption
Q39168776Antimicrobial Dendrimeric Peptides: Structure, Activity and New Therapeutic Applications
Q66679626Antimicrobial Gold Nanoclusters: Recent Developments and Future Perspectives
Q89860099Antimicrobial Peptides: Virulence and Resistance Modulation in Gram-Negative Bacteria
Q90584464Antimicrobial peptides: new hope in the war against multidrug resistance
Q39311394Antimicrobial resistance: The complex challenge of measurement to inform policy and the public
Q88257618Antimicrobial resistance: an urgent need for a planetary and ecosystem approach
Q60124362Application of dynamic modelling techniques to the problem of antibacterial use and resistance: a scoping review
Q60956911Applications of Noble Metal-Based Nanoparticles in Medicine
Q64091723Assessment of knowledge and attitude trends towards antimicrobial resistance (AMR) among the community members, pharmacists/pharmacy owners and physicians in district Sialkot, Pakistan
Q58611181Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Q58571995Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
Q94545226Cell-Free DNA: An Underestimated Source of Antibiotic Resistance Gene Dissemination at the Interface Between Human Activities and Downstream Environments in the Context of Wastewater Reuse
Q58772256Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice
Q92494183Characterization of Biological Resistance and Successful Drug Resistance Control in Medicine
Q51745780Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent Staphylococcus aureus Bacteriophage.
Q92784032Chloramphenicol Resurrected: A Journey from Antibiotic Resistance in Eye Infections to Biofilm and Ocular Microbiota
Q64269492Communicating antimicrobial resistance and stewardship in the national press: Lessons from sepsis awareness campaigns
Q92110552Communication strategies for improving public awareness on appropriate antibiotic use: Bridging a vital gap for action on antibiotic resistance
Q59521527Converging and emerging threats to health security
Q64291023Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure
Q64936972Definition of a Family of Nonmobile Colistin Resistance (NMCR-1) Determinants Suggests Aquatic Reservoirs for MCR-4.
Q91631789Detection of antibiotic-resistant bacteria and their resistance genes from houseflies
Q90404446Development of a Robust and Quantitative High-Throughput Screening Method for Antibiotic Production in Bacterial Libraries
Q47765000Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Q89600901ESKAPE Bacteria and Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolated from Wastewater and Process Water from German Poultry Slaughterhouses
Q63400182Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study
Q50041908Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model
Q53689673Estimating the burden of antimicrobial resistance: a systematic literature review.
Q90925083Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study
Q38599622Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations
Q96123202Expanding the spectrum of antibiotics capable of killing multi-drug resistant Staphylococcus aureus and Pseudomonas aeruginosa
Q89338599Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?
Q92639604Filling the gaps in global antimicrobial resistance research/surveillance
Q57421040Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories
Q60947141Genome Mining of sp. YIM 130001 Isolated From Lichen Affords New Thiopeptide Antibiotic
Q90086365Health Professions Digital Education on Antibiotic Management: Systematic Review and Meta-Analysis by the Digital Health Education Collaboration
Q92471376Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model
Q92637163Healthcare Associated Infections: An Interoperable Infrastructure for Multidrug Resistant Organism Surveillance
Q90194136High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico
Q64979127Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016.
Q54985894Human Activity Determines the Presence of Integron-Associated and Antibiotic Resistance Genes in Southwestern British Columbia.
Q57664374Hydroxybenzylidene-indolinones, c-di-AMP synthase inhibitors, have antibacterial and anti-biofilm activities and also re-sensitize resistant bacteria to methicillin and vancomycin
Q123351349Identification of a Family of Glycoside Derivatives Biologically Active against Acinetobacter baumannii and Other MDR Bacteria Using a QSPR Model
Q64964600Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1).
Q92707025Improving the estimation of the global burden of antimicrobial resistant infections
Q92663733In Silico and In Vitro Experimental Studies of New Dibenz[b,e]oxepin-11(6H)one O-(arylcarbamoyl)-oximes Designed as Potential Antimicrobial Agents
Q92437903Indole hybridized diazenyl derivatives: synthesis, antimicrobial activity, cytotoxicity evaluation and docking studies
Q57807508Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories
Q88508228Keeping the faith - reporting on antimicrobial resistance in an era of fake news
Q53742314Keeping the faith-reporting on antimicrobial resistance in an era of fake news.
Q90696464Low incidence of antibiotic-resistant bacteria in south-east Sweden: An epidemiologic study on 9268 cases of bloodstream infection
Q101237290Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains
Q92854535Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis
Q90356059Mixed-charge pseudo-zwitterionic mesoporous silica nanoparticles with low-fouling and reduced cell uptake properties
Q92875295Mobilizable antibiotic resistance genes are present in dust microbial communities
Q97644491Mobilization of Antibiotic Resistance: Are Current Approaches for Colocalizing Resistomes and Mobilomes Useful?
Q90261518Molecular and Microbial Microenvironments in Chronically Diseased Lungs Associated with Cystic Fibrosis
Q90264432No global increase in resistance to antibiotics: a snapshot of resistance from 2001 to 2016 in Marseille, France
Q57130953Non-Antimicrobial Drugs: Etodolac as a Possible Antimicrobial or Adjuvant Agent Against ESKAPE Pathogens
Q91742543Novel antibiotics effective against gram-positive and -negative multi-resistant bacteria with limited resistance
Q41109803Pandemics, public health emergencies and antimicrobial resistance - putting the threat in an epidemiologic and risk analysis context
Q59128002Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
Q99588371Phyto-nano-hybrids of Ag-CuO particles for antibacterial activity against drug-resistant pathogens
Q100472430Phytochemical conjugation as a potential semisynthetic approach toward reactive and reuse of obsolete sulfonamides against pathogenic bacteria
Q99580010Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance
Q90220917Prescription of antibiotics after tooth extraction in adults: a nationwide study in Korea
Q95601126Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention
Q58611182Public health burden of antimicrobial resistance in Europe
Q90079603Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies
Q91650831Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods
Q64120325Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains
Q64239746Rapid molecular detection of macrolide resistance
Q64986806Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study.
Q98290025Sale of WHO AWaRe groups antibiotics without a prescription in Pakistan: a simulated client study
Q102221234Semi-synthetic vitamin E derivatives as potent antibacterial agents against resistant Gram-positive pathogens
Q89554294Social science research contributions to antimicrobial resistance: protocol for a scoping review
Q90643404Spread of MCR-3 Colistin Resistance in China: An Epidemiological, Genomic and Mechanistic Study
Q90968488Standardising the reporting of microbiology and antimicrobial susceptibility data
Q46268910Surveillance for control of antimicrobial resistance
Q64465697Suspended Materials in River Waters Differentially Enrich Class 1 Integron- and IncP-1 Plasmid-Carrying Bacteria in Sediments
Q57174160Tackling the Antibiotic Resistance Caused by Class A -Lactamases through the Use of -Lactamase Inhibitory Protein
Q92404364The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant Staphylococcus aureus
Q90024194The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study
Q100634197The safety profile of Bald's eyesalve for the treatment of bacterial infections
Q90264507Transmission Routes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in a Neonatology Ward in Madagascar
Q90458303Trends and impact of antimicrobial resistance on older inpatients with urinary tract infections (UTIs): A national retrospective observational study
Q89692180Underrated Staphylococcus species and their role in antimicrobial resistance spreading
Q47606815Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance
Q61801525Using the best available data to estimate the cost of antimicrobial resistance: a systematic review
Q61444724Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa
Q57835596Where Did They Come from-Multi-Drug Resistant Pathogenic in a Cemetery Environment?
Q90295102[Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options]

Search more.